Brain tumors are abnormal growths of cells within the brain or central nervous system that can be benign or malignant. They pose a serious threat due to their location and potential interference with critical neural functions such as speech, movement, and memory. Early diagnosis, accurate classification, and advanced treatment strategies are vital to improving patient survival and quality of life.

The Brain Tumors session explores the molecular biology, genetics, and clinical management of both primary and metastatic brain tumors. It highlights breakthroughs in molecular profiling and immunotherapy that are reshaping modern neuro-oncology. Researchers are now focusing on identifying specific biomarkers to guide precision treatment and minimize recurrence.

At the Brain Tumor Conference, scientists and clinicians share progress in MRI spectroscopy, PET imaging, and intraoperative mapping that enhance diagnostic accuracy. Discussions include the use of targeted radiotherapy, minimally invasive surgery, and novel drug-delivery systems that cross the blood–brain barrier. Personalized medicine approaches are rapidly transforming treatment protocols for gliomas, meningiomas, and pediatric tumors.

This session provides a comprehensive platform for neurosurgeons, oncologists, neuropathologists, and radiologists to discuss evolving standards of care. It also covers patient rehabilitation, quality of life, and psychosocial support systems for long-term survivors.

Ongoing advances in Neuro-Oncology continue to redefine the treatment landscape, moving toward integrated, multidisciplinary approaches for brain-tumor management.